Related Experiment Videos
Dipyrimidine-based inhibitors of HIV-1 integrase
1Department of Pharmaceutical Sciences, University of Southern California, School of Pharmacy, 1985 Zonal Avenue, Los Angeles, USA. neamati@usc.edu
Expert Opinion on Investigational Drugs
|January 31, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Identification and characterization of novel hepcidin mimetics that modulate ferroportin function.
Blood. Red cells & iron·2026
Mechanisms and Design Principles of Proteolysis-Targeting Chimeras and Their Emerging Applications.
ACS pharmacology & translational science·2026
Guizhi-Fuling Wan suppresses carcinoma-associated mesenchymal stem cells-induced ovarian cancer progression via STAT3 inhibition.
Phytomedicine : international journal of phytotherapy and phytopharmacology·2025
Peripheral cannabinoid-1 receptor antagonists in clinical development: therapeutic potential for the management of obesity and related metabolic disorders.
Expert opinion on investigational drugs·2026
Telisotuzumab adizutecan for metastatic colorectal cancer: a c-MET-targeted antibody-drug conjugate with a topoisomerase inhibitor payload.
Expert opinion on investigational drugs·2026
Taxane therapy in mCRPC: current positioning and emerging strategies to overcome resistance.
Expert opinion on investigational drugs·2026
Receptor interacting protein kinase 1 as a potential therapeutic target in inflammatory bowel disease: biological rationale and emerging clinical evidence.
Expert opinion on investigational drugs·2026
Budigalimab: a viable option for patients with advanced solid tumors.
Expert opinion on investigational drugs·2026
Cognitive-enhancing drugs in Phase II clinical trials for Alzheimer's disease: emerging therapeutic candidates.
Expert opinion on investigational drugs·2026
De Novo Molecular Design and Bioactivity Prediction of Novel Hexahydroquinolines as Plasmodium falciparum Calcium-Dependent Protein Kinase 4 (CDPK4) Inhibitors.
Bioinformatics and biology insights·2026